Exelixis (EXEL) Capital Expenditures (2010 - 2026)
Exelixis' Capital Expenditures was $6.82 million in Q2 2027, up 140.2% from $2.84 million a year earlier and up 351.7% from the prior quarter.
Powered by 
Analysis
Exelixis (EXEL) Capital Expenditures (2010 - 2026) Analysis & Trends
On a trailing twelve-month basis, Exelixis' Capital Expenditures was $10.96 million through Jul 3, 2026, down 39.0% year-over-year; for FY2026, it came in at $8.43 million, down 70.4% from FY2025.
- Capital Expenditures shows a five-year compound annual growth rate of -31.1% (FY2021 to FY2026).
- In earlier years, Capital Expenditures was $28.44 million in FY2025, $40.47 million in FY2023 (+46.1%) and $27.71 million in FY2022 (-48.9%).
- The Q2 2027 figure marks the highest quarterly Capital Expenditures since Q3 2025.
- Compared with a year earlier, Capital Expenditures was higher in 1 of the last six quarters, with an average decline of 31.3%.
- Per Business Quant data, EXEL's Capital Expenditures in the three quarters before Q2 2027 was $1.51 million (Q1 2027), $1.16 million (Q4 2026) and $1.48 million (Q3 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 1.32 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 322.00 Mn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 893.00 Mn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | -321.00 Mn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -763.00 Mn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 513.00 Mn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 140.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 533.00 Mn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 112.20 Mn |
| 10 | Exelixis | 14.54 Bn | 10.87 Bn | 608.03 Mn | 6.82 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jul 3, 2026 | 6.82 Mn |
| Apr 3, 2026 | 1.51 Mn |
| Jan 2, 2026 | 1.16 Mn |
| Oct 3, 2025 | 1.48 Mn |
| Jul 4, 2025 | 2.84 Mn |
| Apr 4, 2025 | 2.95 Mn |
| Jan 3, 2025 | 3.98 Mn |
| Sep 27, 2024 | 8.20 Mn |
| Jun 28, 2024 | 6.57 Mn |
| Mar 29, 2024 | 9.69 Mn |
| Dec 29, 2023 | 13.14 Mn |
| Sep 29, 2023 | 9.37 Mn |
| Jun 30, 2023 | 5.94 Mn |
| Mar 31, 2023 | 12.02 Mn |
| Dec 30, 2022 | 9.72 Mn |
| Sep 30, 2022 | 5.04 Mn |
| Jul 1, 2022 | 7.34 Mn |
| Apr 1, 2022 | 5.61 Mn |
| Dec 31, 2021 | 5.96 Mn |
| Oct 1, 2021 | 14.50 Mn |
API Access
Exelixis Capital Expenditures API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=capital-expenditures&ticker=EXEL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "capital-expenditures", "ticker": "EXEL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=capital-expenditures&ticker=EXEL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();